Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
US manufacturers want to market pre-natal screening kits for anencephaly and spina bifida. But can US medicine cope with the risks? David Dickson reports
